Figure 2.
Changes in the clinical disease activity index (CDAI) and the psoriasis area-and-severity index (PASI) score for case 2 during tocilizumab therapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.